Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

2021 Joint Pre-ECTRIMS Live Online Workshop

2021 Joint Pre-ECTRIMS Live Online Workshop
  • Neurology
  • Multiple sclerosis
Online Conference
Monday, Oct 11 - Tuesday, Oct 12 2021
Online, Switzerland



Event format

Workshop session


EXCEMED, in collaboration with the European Charcot Foundation (ECF) and AcademicCME, is planning a Virtual Course to be held prior to the ECTRIMS Congress.


The 2021 Joint Pre-ECTRIMS Live Online Workshop is endorsed by ECTRIMS.


This live, Online Programme will take place at 15.00 (CEST), on both 11th & 12th October, 2021. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.


Understanding and cure of Multiple Sclerosis is rapidly improving through the wide application of new technologies. They are used in all MS fields, like development of biomarkers, sophisticated imaging techniques of central nervous system, new drugs with innovative targets as well as new tools for remote patients monitoring.

The recent COVID-19 pandemic has boosted these processes that were already in place in MS in the past years. Nevertheless, the pandemic has also highlighted the need of new information and deep knowledge about the impact of viruses on immunocompromised hosts, such as MS patients, and of vaccines.

There are still many controversial themes, such as how to manage progressive MS patients, that are currently debated among neurologists and neuroscientists involved in MS field.

This workshop aims to provide updated scientific insights on the world of contemporary MS. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.

Learning objectives

  • Describe new methods to measure cortical damage and disease severity in MS
  • Illustrate mechanisms of action and safety profile of new MS treatments
  • Describe emerging environmental factors influencing MS development
  • Discuss how to manage vaccines in immunosuppressed MS patients

Accreditation details

This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of International Continuing Nursing Education Credits (ICNECs).

The 2021 Joint Pre-Ectrims Online workshop, online, Switzerland, 11/10/2021-12/10/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.



Scientific programme

AGENDA - Day 1 - October 11th, 2021

15.00-15.10 Welcome & Opening



15.10-15.30 Emerging environmental factors triggering MS: the gut-brain axis

S. Baranzini, US


15.30-15.50 Immunosenescence and MS

A.Bar-Or, Canada


15.50-16.05 Q&A



16.05-16.25 Present and future of treating relapsing MS

F.D. Lublin, US


16.25-16.45 Present and future of treating progression

G. Comi, Italy


16.45-16.55 Break


16.55-17.15 Enhancing recovery: new approaches

L. Leocani, Italy


17.15-17.35 MS and demyelinating diseases in children

B. Banwell, US


17.35-17.50 Q&A



17.50-18.10 Updated Role of MRI in Monitoring MS

F. Barkhof, the Netherlands


18.10-18.30 Diagnosis and monitoring of cognitive functions in MS

I.K. Penner, Germany


18.30-18.45 Q&A


18.45-19.30 Panel Discussion on “Lesson learned from COVID-19”

C. Harris, Canada

A. Perrin Ross, USA

M.A. Robles Sanchez, Spain


19.30 End of Day 1 


AGENDA - Day 2 - October 12th, 2021


15.00-15.20 The PROMS initiative

P. Zaratin, Italy


15.20-15.40 Research, validation and development

P. Vermersch, France


15.40-16.00 Role in clinical management

R. McBurney, US


16.00-16.15 Q&A


16.15-16.25 Break



16.25-16.45 New evidence on the role of oligodendrocytes and OPCs in MS

C. Lubetzki, France


16.45-17.05 Moving fluid biomarkers into the clinic

M. Comabella, Spain

J. Kuhle, Switzerland


17.05-18.00 Round Table: MS care in this and the next pandemic: transcontinental perspective

J. Correale, Argentina 

A. Cross, US

G. Giovannoni, UK


18.00-18.15 Q&A


18.15-18.30 Wrap up and closing remarks


18.30 End of the workshop


Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Sergio Baranzini

Associate Professor In-Residence
Department of Neurology
University of California San Francisco

Amit Bar-Or

Neurologist and Professor
Department of Neurology and Neurosurgery
Clinical Research Unit
Montreal Neurological Institute
Montreal, Canada

Letizia Leocani

Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy

Brenda Banwell

Chief of the Division of Neurology
Children's Hospital of Philadelphia
Philadelphia, United States

Frederik Barkhof

Professor of Neuroradiology
University College of London
London, United Kingdom

Paola Zaratin

Italian Multiple Sclerosis Society (AISM) and Italian Multiple Sclerosis Foundation (FISM)
Genoa, Italy

Patrick Vermersch

Department of Neurosurgery
CHU Lille
Université de Lille
Lille, France

Robert McBurney

Chief Research Officer
Accelerated Cure Project for Multiple Sclerosis
United States

Catherine Lubetzki

Head of the Dept. of Neurology & Coordinator of the MS Center
Department of Neurology
Salpêtrière Hospital

Manuel Comabella

Multiple Sclerosis Center of Catalonia Unit of Clinical Neuroimmunology
Vall d’Hebron University Hospital
Barcelona, Spain

Jens Kuhle

Senior Physician
Head Multiple Sclerosis Centre
University Hospital Basel

Jorge Correale

Department of Neurology
Raúl Carrea Institute for Neurological Research (FLENI)
Buenos Aires, Argentina

Gavin Giovannoni

Chair of Neurology
Department of Neurology
Institute of Cell and Molecular Science
Queen Mary University London & Barts and The London NHS Trust
London, United Kingdom

Anne Cross

Neurologist and MS chair
Department of Neuroimmunology
Washington University School of Medicine in St. Louis

M. A. Robles Sanchez

Multiple Sclerosis Neuroimmunology Unit
Biomedical Research Institute of Girona
Girona, Spain

Amy Perrin Ross

Loyola University Chicago
Chicago, United States
Department of Neurosciences
Loyola University Medical Center
Oak Brook, Illinois, United States

Colleen Harris

Nurse Co-ordinator/Nurse Practitioner
Multiple Sclerosis Clinic
University of Calgary MS Clinic
United States